TrialBritish journal of haematology2013

Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor-bearing microparticles: a randomized-controlled phase II trial (the Microtec study).

Jeffrey I Zwicker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.